EUSA Pharma has been undergoing many changes, but one of the most important changes was bringing Carsten Thiel on board to help out. As a global pharmaceutical company, EUSA Pharma is dedicated to conducting research in the area of oncology and rare diseases. This is why bringing Carsten Thiel on board was such a great idea for the company.
He was chosen to be the president for the company for numerous reasons. One of them includes his experience in having worked for nearly 30 years with commercial experience. He has worked both in the USA and abroad in his chosen industry. This speaks volumes about his level of experience and his ability to build relationships with others regardless of their background.
One of the positions he had held prior was with Abeona Therapeutics Inc. He was also the Chief Commercial Officer for another pharmaceutical company known as Alexion Pharmaceuticals.
His time spent working for other companies in this field gave him the preparation for working in the pharmaceutical industry. As a result, he was also instrumental is leading what is known as the EMEA. This means that he was focused on leading in Europe, Middle East and Africa, along with Australasia.
His education is one of the most important aspects of why he is successful. His education was directly linked to his field. He attended Hoffman La-Roche, where he earned his degree in molecular biology. He later earned his biochemistry in Germany, after attending the Max Planck Institute.
Carsten Thiel is known for his ability to become a welcome addition to any pharmaceutical company. Click here to learn more